YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 3.08 USD -8.06% Market Closed
Market Cap: 58.8m USD
Have any thoughts about
YS Biopharma Co Ltd?
Write Note

YS Biopharma Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

YS Biopharma Co Ltd
Total Equity Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
YS Biopharma Co Ltd
NASDAQ:LSB
Total Equity
ÂĄ585.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Equity
ÂĄ25.1B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Equity
ÂĄ12.4B
CAGR 3-Years
1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Equity
ÂĄ12.7B
CAGR 3-Years
71%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Equity
ÂĄ31.5B
CAGR 3-Years
32%
CAGR 5-Years
47%
CAGR 10-Years
29%
Imeik Technology Development Co Ltd
SZSE:300896
Total Equity
ÂĄ6.3B
CAGR 3-Years
12%
CAGR 5-Years
74%
CAGR 10-Years
N/A

See Also

What is YS Biopharma Co Ltd's Total Equity?
Total Equity
585.2m CNY

Based on the financial report for Mar 31, 2024, YS Biopharma Co Ltd's Total Equity amounts to 585.2m CNY.

What is YS Biopharma Co Ltd's Total Equity growth rate?
Total Equity CAGR 1Y
-20%

Over the last year, the Total Equity growth was -20%.

Back to Top